The "Global Nuclear Medicine Equipment Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023" report has been added to ResearchAndMarkets.com's offering.
The global nuclear medicine equipment market is expected to rise with a CAGR of 3.5% during the forecast period 2016-2023
The key factors driving the market growth are the introduction of new and advanced products, public-private partnerships investments to modernize diagnostic imaging centers, advances in radiotracers, increasing prevalence of cancer and cardiac ailments and rising geriatric population.
Geographically, nuclear medicine equipment market is segmented into Asia Pacific, Europe, North America and ROW. North America is the leading region owing to the technological advancements in nuclear medicine equipment which has led to the increased adoption and growth of nuclear medicine in U.S. Additional factors such as highly developed healthcare infrastructure, emergence of new radiopharmaceuticals for therapeutics and diagnostics, etc. have propelled the North American market growth.
However, Asia Pacific is expected to be the fastest growing region during the forecast period 2016-2023 owing to the increased research and development in the field of nuclear medicine in Asia Pacific countries including China, Japan, India, Australia, etc. Furthermore, increasing prevalence of cardiovascular and neurological diseases such as cancer, cardiovascular diseases, Alzheimer's, Parkinson's, etc., and rising geriatric population, growing healthcare expenditure, has led to surging demand for nuclear medicine equipment.
The global nuclear medicine equipment market is influenced by the presence of leading companies such as CMR Naviscan Corporation, GE Healthcare, Hitachi Medical Corporation, Medtronic Inc., Siemens AG etc. Merger and acquisition, product launch and joint venture are some of the crucial strategies adopted by the key market players to gain competitive advantage.
Key Topics Covered:
1. Introduction
2. Market Overview
3. Market Determinants
4. Market Segmentation
5. Competitive Landscape
6. Geographic Analysis
7. Company Profiles
- CMR Naviscan Corporation (U.S.)
- DDD-Diagnostic A/S (Denmark)
- Digirad Corporation (U.S.)
- Fujifilm Holdings (Japan)
- GE Healthcare (UK)
- Hitachi Medical Corporation (Japan)
- Hologic (U.S.)
- Mediso Medical Imaging Systems Ltd (Hungary)
- Medtronic Inc. (U.S.)
- Neusoft Medical Systems Co. Ltd. (China)s
- Philips Healthcare (Netherlands)
- Shimadzu Corporation (Japan)
- Siemens Ag (Germany)
- SurgicEye GmbH (Germany)
- Toshiba Medical Systems Corporation (Japan)
For more information about this report visit https://www.researchandmarkets.com/research/zwx7s6/global_nuclear?w=4
View source version on businesswire.com: http://www.businesswire.com/news/home/20180209005657/en/
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Nuclear
Medicine and Radiopharmacology